Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.
Clinical trial NCT02209948 · COMPLETED
Trial details
- NCT number
- NCT02209948
- Sponsor
- Grupo Español de Investigación en Neurooncología
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-22
- Primary completion
- 2019-06-01
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.